Skip to main content
  • Commentary on the TRYTON Dedicated Bifurcation Stent: 5-Year Clinical Outcomes

    Bifurcations constitute up to 20% of all percutaneous coronary interventions. Both the NORDIC I and British Bifurcation Coronary trials compared a two-stent strategy with main vessel (MV) stenting and provisional stenting of the side branch (SB). They consistently revealed a higher peri-procedural rate of myocardial infarction (MI) in the two-stent strategy, making provisional stenting the default strategy.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details